Background. Cancer mortality has been stated to be the best single measure of progress in combatting cancer. The variation in total and cause-specific cancer mortality among health administrative areas in Sweden was analysed in order to find out if the mortality outcome has been equally distributed. Methods. Data on underlying causes of death for ages 0-74 years were analysed for the 26 health administrative areas in Sweden, 1975-1990. Analyses of systematic (non-random) variance were performed and measures chosen in order to make comparisons possible between different malignant neoplasms and different periods of time. Results. The systematic variance for all malignant neoplasms was reduced by about 40 % during the study period. The largest...
Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites ...
Trends in mortality in the age group 20-44 years for the 16 most common cancers or groups of cancer ...
BACKGROUND: Mortality information is essential for estimating relative cancer survival (that exclude...
Analysis of mortality from breast cancer in selected European countries Malignant neoplasms are in m...
All ages and truncated (35 to 64 years) mortality rates from all neoplasms and from cancers of the l...
All ages and truncated (35 to 64 years) mortality rates from all neoplasms and from cancers of the l...
Cancer survival varies substantially across population groups. For instance, there are differences a...
Trends in death certification rates from all cancers and seven selected cancer sites (bone sarcoma, ...
Analyses of data from cancer registries have shown a 10% unit difference in 5-year relative survival...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
Cancer mortality has declined over the last three decades in most high-income countries reflecting i...
In all of the developed countries, malignant neoplasms are, along with cardiovascular diseases, amon...
Cancer survival is a key measure of the effectiveness of health-care systems. Persistent regional an...
SUMMARY-In the.tudy of geographical distribution of deaths From cancer in Iceland, an aHempt was mad...
Cancer mortality has declined over the last three decades in most high-income countries reflecting i...
Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites ...
Trends in mortality in the age group 20-44 years for the 16 most common cancers or groups of cancer ...
BACKGROUND: Mortality information is essential for estimating relative cancer survival (that exclude...
Analysis of mortality from breast cancer in selected European countries Malignant neoplasms are in m...
All ages and truncated (35 to 64 years) mortality rates from all neoplasms and from cancers of the l...
All ages and truncated (35 to 64 years) mortality rates from all neoplasms and from cancers of the l...
Cancer survival varies substantially across population groups. For instance, there are differences a...
Trends in death certification rates from all cancers and seven selected cancer sites (bone sarcoma, ...
Analyses of data from cancer registries have shown a 10% unit difference in 5-year relative survival...
Trends in age-standardised mortality for all cancers and 21 cancers or groups of cancers over the pe...
Cancer mortality has declined over the last three decades in most high-income countries reflecting i...
In all of the developed countries, malignant neoplasms are, along with cardiovascular diseases, amon...
Cancer survival is a key measure of the effectiveness of health-care systems. Persistent regional an...
SUMMARY-In the.tudy of geographical distribution of deaths From cancer in Iceland, an aHempt was mad...
Cancer mortality has declined over the last three decades in most high-income countries reflecting i...
Mortality data, abstracted from the WHO database, are presented in tabular form for 26 cancer sites ...
Trends in mortality in the age group 20-44 years for the 16 most common cancers or groups of cancer ...
BACKGROUND: Mortality information is essential for estimating relative cancer survival (that exclude...